跳到內容

跳到副選單

耶和華見證人

中文繁體(國語)

成人乙型地中海貧血

重度乙型地中海貧血——經由藥物誘導體內胎兒血紅蛋白的合成

Efficacy of hydroxyurea in providing transfusion independence in β-thalassemia.

Ansari SH, Shamsi TS, Ashraf M, Perveen K, Farzana T, Bohray M, Erum S, Mehboob T.

出處‎: J Pediatr Hematol Oncol 2011;33(5):339-43.

檢索‎: PubMed 21602718

DOI碼‎: 10.1097/MPH.0b013e31821b0770

http://www.ncbi.nlm.nih.gov/pubmed/21602718

Hydroxyurea treatment in β-thalassemia patients: to respond or not to respond?

Banan M.

出處‎: Ann Hematol 2013;92(3):289-99.

檢索‎: PubMed 23318979

DOI碼‎: 10.1007/s00277-012-1671-3

http://www.ncbi.nlm.nih.gov/pubmed/23318979

Preliminary results with administration of recombinant human erythropoietin in sickle cell/beta-thalassemia patients during pregnancy.

Bourantas K, Makrydimas G, Georgiou J, Tsiara S, Lolis D.

出處‎: Eur J Haematol 1996;56(5):326-8.

檢索‎: PubMed 8641410

http://www.ncbi.nlm.nih.gov/pubmed/8641410

Decreased transfusion needs associated with hydroxyurea therapy in Algerian patients with thalassemia major or intermedia.

Bradai M, Pissard S, Abad MT, Dechartres A, Ribeil JA, Landais P, de Montalembert M.

出處‎: Transfusion 2007;47(10):1830-6.

檢索‎: PubMed 17880608

http://www.ncbi.nlm.nih.gov/pubmed/17880608

Induction of fetal hemoglobin synthesis with recombinant human erythropoietin in anemic patients with heterozygous beta-thalassemia during pregnancy.

Breymann C, Fibach E, Visca E, Huettner C, Huch A, Huch R.

出處‎: J Matern Fetal Med 1999;8(1):1-7.

檢索‎: PubMed 10052837

http://www.ncbi.nlm.nih.gov/pubmed/10052837

Treatment of beta-thalassemia patients with recombinant human erythropoietin: effect on transfusion requirements and soluble adhesion molecules.

Chaidos A, Makis A, Hatzimichael E, Tsiara S, Gouva M, Tzouvara E, Bourantas KL.

出處‎: Acta Haematol 2004;111(4):189-95.

檢索‎: PubMed 15153710

http://www.ncbi.nlm.nih.gov/pubmed/15153710

Hydroxyurea increases hemoglobin F levels and improves the effectiveness of erythropoiesis in beta-thalassemia/hemoglobin E disease.

Fucharoen S, Siritanaratkul N, Winichagoon P, Chowthaworn J, Siriboon W, Muangsup W, Chaicharoen S, Poolsup N, Chindavijak B, Pootrakul P, Piankijagum A, Schechter AN, Rodgers GP.

出處‎: Blood 1996;87(3):887-92.

檢索‎: PubMed 8562958

http://www.ncbi.nlm.nih.gov/pubmed/8562958

Hydroxyurea can reduce or eliminate transfusion requirements in children with major and intermediate thalassemia.

Hashemi A, Abrishamkar M, Jenabzade AR, Eslami Z.

出處‎: Iran J Blood Cancer 2009;1(4):147-50.

檢索‎: IMEMR 107228

http://www.ijbc.ir/browse.php?a_id=4&sid=1&slc_lang=en

Hydroxyurea as a first-line treatment of extramedullary hematopoiesis in patients with beta thalassemia: Four case reports.

Karimi M, Cohan N, Pishdad P.

出處‎: Hematology. 2015;20(1):53-7.

檢索‎: PubMed 24717020

DOI碼‎: 10.1179/1607845414Y.0000000168

http://www.ncbi.nlm.nih.gov/pubmed/24717020

Genotype-phenotype relationship of patients with β-thalassemia taking hydroxyurea: a 13-year experience in Iran.

Karimi M, Haghpanah S, Farhadi A, Yavarian M.

出處‎: Int J Hematol 2012;95(1):51-6.

檢索‎: PubMed 22180324

DOI碼‎: 10.1007/s12185-011-0985-6

http://www.ncbi.nlm.nih.gov/pubmed/22180324

Recombinant human erythropoietin therapy in a transfusion-dependent β-thalassemia major patient.

Makis AC, Chaliasos N, Hatzimichael EC, Bourantas KL.

出處‎: Ann Hematol 2001;80(8):492-5.

檢索‎: PubMed 11563599

http://www.ncbi.nlm.nih.gov/pubmed/11563599

Clinical experience with fetal hemoglobin induction therapy in patients with β-thalassemia.

Musallam KM, Taher AT, Cappellini MD, Sankaran VG.

出處‎: Blood 2013;121(12):2199-212.

檢索‎: PubMed 23315167

DOI碼‎: 10.1182/blood-2012-10-408021

http://www.ncbi.nlm.nih.gov/pubmed/23315167

Fetal globin gene inducers: novel agents and new potential.

Perrine SP, Castaneda SA, Chui DH, Faller DV, Berenson RJ, Siritanaratku N, Fucharoen S.

出處‎: Ann N Y Acad Sci 2010;1202:158-64.

檢索‎: PubMed 20712788

DOI碼‎: 10.1111/j.1749-6632.2010.05593.x

http://www.ncbi.nlm.nih.gov/pubmed/20712788

Fetal globin induction--can it cure beta thalassemia?

Perrine SP.

出處‎: Hematology Am Soc Hematol Educ Program 2005:38-44.

檢索‎: PubMed 16304357

http://www.ncbi.nlm.nih.gov/pubmed/16304357

Response to hydroxyurea treatment in Iranian transfusion-dependent beta-thalassemia patients.

Yavarian M, Karimi M, Bakker E, Harteveld CL, Giordano PC.

出處‎: Haematologica 2004;89(10):1172-8.

檢索‎: PubMed 15477200

http://www.ncbi.nlm.nih.gov/pubmed/15477200

Hydroxyurea therapy in 49 patients with major beta-thalassemia.

Zamani F, Shakeri R, Eslami SM, Razavi SM, Basi A.

出處‎: Arch Iran Med 2009;12(3):295-7.

檢索‎: PubMed 19400608

http://www.ncbi.nlm.nih.gov/pubmed/19400608


JW.ORG​網站​內​的​醫療​資訊​主要​是​提供​給​醫生​及​醫療人員​參考,而​不​是​要​提供​診斷​建議​或​推薦​某​種​醫療​方法,也​不​是​要​取代​專業​的​醫療​護理。網站​上​引用​的​許多​醫學​文章​都​不​是​耶和華見證人​出版​的,但​當​中​提​到​了​許多​替代​輸​血​的​療法,這些​醫療​策略​很​值得​醫生​參考。每​一​個​專業​醫療人員​都​有​責任​經常​吸收​最​新​的​醫療​資訊,討論​最​適合​病人​的​醫療​方法。他們​也​要​根據​病人​的​病情、意願、價值觀​和​信仰​來​協助​病人​選擇​最佳​的​醫療​方式。本​網站​所​提供​的​醫療​策略​不​一定​適用​於​每​一​個​病人。

給​病人​的​建議:當​你​感到​身體​不適,要​立刻​尋求​醫生​的​幫助,也​要​聽取​醫生​以及​其他​專業​醫療人員​的​建議。

使用​本​網站​即​表示​你​接受​本使用​條款的​全部​內容。